ng, strong collaboration with key industry associations, and support from national authorities, PHARMEX has secured a unique position among regional and international trade shows.
Unique Identity and Competitive Advantages of PHARMEX:
1. Specialization: A focused approach on APIs, supply chain integration, and export-oriented development.
2. Institutional Support: Governance through a Policy Council comprising the Food and Drug Administration, Ministry of Industry (MIMT), Ministry of Oil, and core pharmaceutical associations.
3. Educational and Technological Platform: Hosting technical workshops, scientific panels, and fostering joint investment opportunities.
4. Export Orientation: Highlighting Iran’s export capabilities and creating global investment prospects.
Conclusion: PHARMEX 2025 is more than just a pharmaceutical exhibition,it’s a strategic platform showcasing national capabilities, fostering exports, and enabling international networking. With continued government support, operational professionalism, and expanded global outreach, PHARMEX is poised to become a central hub for industrial pharmaceutical diplomacy in the region.